The results of a recently concluded drug trial may offer hope for Alzheimer’s patients. The drug lecanemab appeared to slow cognitive decline by 27 percent in trial participants (early-stage Alzheimer’s patients), compared to a group that received a placebo. That is considered a significant impact and could potentially be groundbreaking, leading to further drug development. … Continue reading New Drug for Alzheimer’s Patients
